Wal-Mart records surge in on-line drug sales

20 November 2006

Wal-Mart, the world's largest retailer, whose $4 per month discounted generic drug program (Marketletters passim) triggered a price war in the US pharmacy market, has reported a massive increase in the number of Internet orders it has processed since the scheme began in late September.

Walmart.com (Wal-Mart's on-line outlet) chief executive Carter Cast told the Bloomberg news service that the site had recorded "triple-digit growth" in generic drug sales since the $4 program started, the biggest surge in any of the store's sales areas since the web site was launched in 1996.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight